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ABSTRACT Although x-ray crystal structures exist for many forms of insulin, the hormone involved in glucose metabolism
and used in the treatment of diabetes, x-ray structural characterization of therapeutically important long-acting crystalline
ultralente insulin forms has been elusive because of small crystal size and poor diffraction characteristics. We describe
tapping-mode atomic force microscopy (TMAFM) studies, performed directly in crystallization liquor, of ultralente crystals
prepared from bovine, human, and porcine insulins. Lattice images obtained from direct imaging of crystal planes are
consistent with R3 space group symmetry for each insulin type, but the morphology of the human and porcine crystals
observed by AFM differs substantially from that of the bovine insulin crystals. Human and porcine ultralente crystals exhibited
large, molecularly flat (001) faces consisting of hexagonal arrays of close packed hexamers. In contrast, bovine ultralente
crystals predominantly exhibited faces with cylindrical features assignable to close-packed stacks of insulin hexamers laying
in-plane, consistent with the packing motif of the (010) and (011) planes. This behavior is attributed to a twofold increase in
the hydrophobic character of the upper and lower surfaces of the donut-shaped insulin hexamer in bovine insulin compared
to its human and porcine counterparts that results from minor sequence differences between these insulins. The increased
hydrophobicity of these surfaces can promote hexamer-hexamer stacking in precrystalline aggregates or enhance attach-
ment of single hexamers along the c axis at the crystal surface during crystal growth. Both events lead to enhanced growth
of {hk0} planes instead of (001). The insulin hexamers on the (010) and (110) faces are exposed “edge-on” to the aqueous
medium, such that solvent access to the center of the hexamer and to solvent channels is reduced compared to the (001)
surface, consistent with the slower dissolution and reputed unique basal activity of bovine ultralente insulin. These obser-
vations demonstrate that subtle variations in amino acid sequence can dramatically affect the interfacial structure of
crystalline proteins.
INTRODUCTION
Insulin is a 5808-Da, 51 amino acid, dual-chain hormone
that is secreted and stored in pancreatic -cells. It has a
significant history, owing to its therapeutic importance for
the treatment of diabetes, a chronic disease that often re-
quires supplemental insulin delivered by subcutaneous in-
jection of either solution or microcrystalline suspension
formulations (Haycock, 1983). The pharmacokinetics of
such therapies are dictated to a large extent by dissociation
of the insulin zinc-hexamer to the bioactive monomer (Hol-
lenberg, 1990; Gammeltoft, 1988; Berson and Yalow, 1966;
Smith et al., 1984). The therapeutic efficacy of microcrys-
talline insulin suspensions also may be influenced by the
rate of hexamer dissociation from the crystal lattice, which
would depend upon the cohesive energy between insulin
hexamers, crystal morphology, the dissolution rates of dif-
ferent crystal faces, and the degree of disorder at the crystal-
solution interface.
First prepared by Schlichtkrull, crystalline ultralente in-
sulin is a commercially available, long-acting insulin prep-
aration (Hallas-Møller et al., 1952; Schlichtkrull, 1956).
Remarkably, despite its long history, this form has defied
high-resolution structural analysis, owing to poor diffrac-
tion characteristics and small crystal dimensions. The lack
of molecular-level structural characterization of ultralente
crystals has hampered efforts to design more effective basal
insulin preparations and has precluded understanding of the
subtle yet therapeutically important differences in the phar-
macokinetic characteristics of bovine, human, and porcine
ultralente insulin (Galloway and Chance, 1994). Crystalline
bovine ultralente insulin—which differs from human and
porcine insulins by two residues in the A-chain—is reputed
to provide optimal pharmacokinetics with a relatively con-
stant plasma insulin concentration, mimicking that present
in nondiabetic individuals. However, it remains unclear how
the pharmacokinetics, governed by the dissolution of the
microcrystals and insulin monomer absorption into the
bloodstream, is related to factors such as the conformation
of individual insulin molecules, hexamer packing in the
solid state, and crystal morphology (Graham and Pomeroy,
1984). Furthermore, little is known about the role of the
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aforementioned sequence differences on crystal dissociation
or growth.
We recently reported that insulin polymorphs, the struc-
ture of specific crystal faces, and the influence of sequence
modifications on insulin crystal growth and interfacial
structure could be characterized directly by in situ atomic
force microscopy (AFM) (Yip et al., 1996, 1998). These
studies have added to the emergence of AFM as an ideal
technique for characterizing the crystal-solution interface
and elucidating crystal growth and dissolution processes of
small molecule crystals (Mao et al., 1997; Last and Ward,
1996; Hillier and Ward., 1994; Hillier et al., 1994; Carter et
al., 1994) and protein crystals (Kuznetsov et al., 1997;
Malkin et al., 1995, 1996; Land et al., 1995, 1996; McPher-
son et al., 1996; Walz et al., 1996; Konnert et al., 1994;
Durbin et al., 1992, 1993). AFM is also particularly well
suited to the analysis of two-dimensional protein arrays
(Muller et al., 1997; Walz et al., 1996; Schabert et al., 1995;
Lyon et al., 1993).
These capabilities and the lack of structural characteriza-
tion of the therapeutically important ultralente insulins
prompted us to study microcrystals of these forms by AFM.
A previous study in our laboratories of an insulin analog
that differed from native human insulin by an inversion of
lysyl and prolyl residues at positions 28 and 29 in the B
chain demonstrated that this minor sequence change af-
fected crystal growth characteristics and lattice defects in a
manner that reflected reduced cohesive energy between
hexamers (Yip et al., 1998). This suggests that the sequence
difference between bovine and human/porcine insulins may
affect the interfacial structure of ultralente crystals, which
can be probed directly with AFM. We describe herein the
structural characterization of specific crystal faces of ultra-
lente crystals by in situ AFM. Lattice images indicate that
each type crystallizes in the R3 space group, but bovine
ultralente insulin exhibits a crystal morphology that differs
substantially from that of the human and porcine insulins.
This is attributed to a greater hydrophobicity on critical
external surfaces of the bovine insulin hexamers that favors
hexamer-hexamer association into close-packed stacks
along the c axis rather than the lateral hexamer-hexamer
association into (001) layers observed for human and por-
cine insulins. The morphology observed for bovine ultra-
lente and the close-packed nature of the exposed planes
suggest that its unique pharmacokinetics is due to inhibited
solvent ingress and reduced dissolution rates compared to
the human and porcine forms.
MATERIALS AND METHODS
Crystallization
Single crystals of ultralente insulin were prepared from wild-type bovine,
porcine, and recombinant human insulins (Eli Lilly and Company) by batch
crystallization (Schlichtkrull, 1956). To a precleaned 20-ml glass scintil-
lation vial containing 30 mg of insulin was added 3 ml of 0.02 M HCl.
After gentle swirling to dissolve the insulin, 24 l aqueous 12 weight %
ZnCl2, 0.36 g NaCl, and 2 ml of 0.2 M sodium citrate buffer were added
sequentially to afford a slightly turbid solution. The pH of the crystalliza-
tion liquor was adjusted to 6.25 with dilute sodium hydroxide, and the
ensuing clear solution was allowed to stand at room temperature.
Atomic force microscopy
All images were acquired in solution on a Digital Instruments Nanoscope
IIIA MultiMode scanning probe microscope (Digital Instruments, Santa
Barbara, CA), using a combination contact/tapping mode liquid cell fitted
with 120-m oxide-sharpened silicon nitride V-shaped cantilevers with
integral bipyramidal tips (Type DNP-S; Digital Instruments). Before use,
the AFM tips were exposed to UV radiation to remove adventitious organic
contaminants from the tip surface. Tapping-mode operation in solution
employs cantilevers with a lower spring constant than typically are used for
tapping mode in air, to compensate for viscous coupling between the tip
and surrounding fluid, which effectively raises the cantilever spring con-
stant. Optimal tapping-mode imaging was achieved at frequencies near 8.9
kHz, although we note that selection of the appropriate drive frequency can
be influenced by the particular cantilever in use, the sample surface, and
solution conditions. The cantilever drive and setpoint imaging voltages
were found to play a significant role in determining image quality and
sample integrity. Slight deviations from the optimal setpoint drive and
imaging voltages during data acquisition led to diminished resolution and,
occasionally, sample etching. Accordingly, the choice of feedback condi-
tions was based on optimized image quality.
All AFM images were acquired with a Digital Instruments “E” scanning
head, which has a maximum lateral scan area of 14.6 m  14.6 m. The
crystals to be examined were transferred via pipette into a well that was
defined by an O-ring placed on an AFM mount coated with a thin layer of
vacuum grease. Once seated on the O-ring, the liquid cell has restricted
lateral translation, making it important to minimize the need for tip posi-
tioning. Therefore, we devised the following procedure to reliably position
the AFM tip over a crystal of interest. The cantilever was mounted in the
AFM liquid cell and the laser spot was aligned on the cantilever tip in
the absence of a sample surface. The liquid cell then was removed from the
AFM optical head and replaced with the AFM mount containing
the crystals of interest. Without adjusting the laser spot positioning screws
and while monitoring the position of the laser spot through an optical
microscope, the AFM optical head is translated in the x-y plane until the
laser spot is located above a crystal of interest. The liquid cell containing
the premounted cantilever tip is then reseated over the O-ring. This
procedure also reduces the incidence of sample creep arising from relax-
ation of the O-ring.
Image analyses were performed on low-pass filtered AFM images,
using Nanoscope III, version 4.22b1 (Digital Instruments), and National
Institutes of Health Image, version 1.61 (National Institutes of Health;
available by anonymous file transfer protocol from zippy.nimh.nih.gov),
software packages.
Molecular modeling
Molecular models of the bovine and human insulin hexamers were gener-
ated in Quanta96 (Molecular Simulations, San Diego, CA), using the 2-Zn
porcine insulin as an initial model. The crystal structure of this form was
retrieved from the Brookhaven Protein Databank (Bernstein et al., 1977;
Abola et al., 1987) as PDB entry code pdb4ins.ent (Baker et al., 1988). The
structures of the modified insulin monomers were minimized using
CHARMM by applying 50 steps of a modified Newton-Raphson minimi-
zation algorithm. The hexamers were then generated from the minimized
structures with the appropriate symmetry operators. This minimization
procedure allows for relaxation of any steric conflicts arising from the
sequence alteration. The minimum energy structure of the 2-Zn porcine
insulin hexamer was determined in the same manner to ensure that the
calculated surface differences were not artifacts of the minimization pro-
cedure. Surface hydrophobicity and hydrophilicity were evaluated with
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GRASP (Nicholls et al., 1991). All modeling was performed on a Silicon
Graphics R3000 Elan workstation.
RESULTS AND DISCUSSION
Tapping-mode AFM imaging was performed directly under
growth conditions in crystallization liquor on bunched ag-
gregates of orthorhombic-shaped microcrystals of human
and porcine insulins that were retrieved from prior crystal-
lization in highly concentrated salt solutions (Schlichtkrull,
1956). Images were acquired on the most prominent face of
a given microcrystal while growth was occurring on that
face. These images revealed large micron-sized, molecu-
larly flat terraces that were occasionally decorated with
protein aggregates. Continued imaging revealed layer-by-
layer growth, identical to previous observations in our lab-
oratory for insulin crystals (Yip et al., 1996, 1998). AFM
lattice images acquired on small regions of these terraces
revealed molecular-scale contrast with nominal hexagonal
order and two-dimensional lattice constants a1  49.0 Å,
a2  44.2 Å, a3  49.0 Å, 12  56°, and 23  57° (Fig.
1). The vertical step height between individual terraces was
30 Å, in good agreement with the thickness of the “donut-
shaped” insulin hexamer (Baker et al., 1988). Inspection of
the AFM images revealed that the terraces were translation-
ally and rotationally commensurate, indicative of good crys-
tal quality. These data are consistent with the close-packed
hexagonal arrangement of insulin hexamers in the (001)
plane of numerous insulin crystals that crystallize in the R3
space group (under conditions different from those of the
ultralente forms) and have been structurally characterized
by single-crystal x-ray diffraction. For example, the dis-
tance between neighboring hexamers in the (001) plane of
the 2-Zn porcine insulin structure (space group: R3, a 
b  82.5 Å, c  35 Å;     90°,   120°) is 46 Å,
in excellent agreement with the two-dimensional lattice
constants observed in the AFM data. Furthermore, 30-Å
vertical separation between these terraces was in reasonable
agreement with the c axis lattice parameter of the 2-Zn
porcine insulin structure.
These data argue that human and porcine ultralente insu-
lins crystallize in the trigonal crystal system, very likely as
R3. This is supported further by a survey of the Brookhaven
Protein Databank that revealed that65% of reported wild-
type and analog insulin structures crystallized in the R3
space group, compared to only 2% of all registered diffrac-
tion structures.
In contrast to the porcine and human ultralente insulins,
crystallization of bovine insulin under identical conditions
yielded micron-sized irregular rhombohedral-shaped crys-
tals with poorly defined crystal facets. Tapping-mode AFM
performed under growth conditions in crystallization liquor
revealed crystal growth modes and surface topographies
that differed significantly from that observed for the human
and porcine analogs (Fig. 2). Instead of hexagonal periodic
contrast, the bovine crystal faces exhibited contrast that can
be described best as bundles of parallel corrugated cylin-
ders. The cylinders repeat at 50-Å intervals, and the
corrugations within a given cylinder repeat at45-Å intervals.
A more careful analysis of the data revealed slightly
different lattice structures on different regions of a crystal.
Lattice images acquired on region 1, on the surface of a
small facet that emerges from the large face in Fig. 2 A,
suggest a two-dimensional oblique unit cell with lattice
constants of a1  40 Å, a2  48 Å, and 12  63° (Fig. 2
B). The oblique cell is a consequence of a lateral offset of
adjacent cylinders. The large face that occupies most of the
FIGURE 1 In situ tapping-mode AFM images of the (001) face of human insulin ultralente crystals acquired in crystallization liquor. (A) Large area scan
revealing well-defined molecular terraces and translational and rotational commensurism between individual terraces. The vertical step height between
terraces is30 Å. Scan rate: 2.0 Hz. (B) Lattice images revealing nominal hexagonal periodicity that is consistent with the expected hexamer packing motif
on the (001) crystal plane of R3 porcine insulin. Scan rate: 2.0 Hz. (Inset) Two-dimensional Fourier power spectrum corresponding to real-space vectors:
a1  49.0 Å, a2  44.2 Å, a3  49.0 Å, 12  56°, and 23  57°, corresponding to lateral nearest-neighbor hexamer-hexamer contacts in the (001) R3
crystal plane (see Fig. 4). The AFM unit cell corresponding to the two-dimensional Fourier power spectrum is depicted by the solid white lines.
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image frame is somewhat rough, consisting of bunches of
cylinders that emerge from kink sites on the crystal surface.
Two different oblique unit cells were evident on various
locations of this large face (region 2), one with lattice
constants a1  43 Å, a2  41 Å, and 12  62°, and the
other with a1  48 Å, a2  70 Å, and 12  65° (Fig. 2 C).
The arrays of ordered corrugated cylinders observed in
the lattice images of bovine ultralente insulin crystals and
the measured lattice constants were consistent with the
surface structure of R3 {hk0} planes, which contain close-
packed stacks (i.e., cylinders) of “donut-shaped” insulin
hexamers along the c axis (Figs. 3 and 4). More specifically,
FIGURE 2 Tapping-mode AFM images of bovine insulin ultralente crystals acquired in crystallization liquor. Corrugated cylindrical features are evident
on the large face. The cylinders are spaced at intervals of 50 Å, and the interval between corrugations within a given cylinder is 45 Å. Scan rate: 2.0
Hz. (A) Large area scan revealing corrugated row structures and a small crystal facet in the upper right-hand corner. (B) Data acquired on a small area of
region 1 that reveals a unit cell with lattice constants a1  40 Å, a2  48 Å, and 12  63°, consistent with packing of insulin hexamers on the (110) plane
of the R3 structure. (C) Data acquired on a small area of region 2 revealing corrugated cylinders. Two distinct unit cells are evident in this region. The
unit cell with lattice constants a1  48 Å, a2  70 Å, and 12  65°, depicted by dashed white lines, is consistent with hexamer organization on the (010)
plane. The second unit cell with lattice constants a1  43 Å, a2  41 Å, and 12  62°, depicted by solid white lines, is consistent with the hexamer
organization on (110).
FIGURE 3 Schematic representation of the insulin hexamer packing on the prominent exposed crystal surfaces of (A) porcine (or human) insulin and (B)
bovine ultralente insulin based on the R3 space group symmetry. In A the exposed surface is the (001) crystal plane, which is defined by close-packed
hexagonal arrays of hexamers. This face, which predominates in porcine and human insulins, provides facile solvent access to the core of the insulin
hexamer that contains the Zn2 ion and to the solvent channels along the c-axis in the crystal. In B, the exposed surfaces correspond to the (010) and (110)
crystal planes, which have close-packed stacks of insulin hexamers that hinder solvent access to the crystal. The arrows depict possible mechanisms of
ultralente crystal growth, which may occur by attachment of single hexamers to growing (001) terraces (for human/porcine insulins in A) or by attachment
of stacked hexamer aggregates to (010) or (110) planes (for bovine insulin in B).
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these images reflect the organization of hexamers on the
(010) and (110) planes in the 2-Zn porcine insulin. Com-
parison of the AFM data with the crystal structure suggests
that the oblique unit cell from the AFM data acquired on
region 1 can be assigned to hexamer organization on the
(010) plane, whereas the observation of two lattices in
region 2 can be attributed to a mixture of (010) and (110).
The (010) unit cell surmised from the AFM data is oblique,
unlike the rectangular cell defined by the a and b lattice
vectors in the crystallographic model. Nevertheless, the
oblique cell is a physically real representation of the hex-
amer organization on the (010) plane (Fig. 4 B). Similarly,
the oblique unit cell observed by AFM assigned to (110) is
one of two unit cell choices (the other being rectangular)
that can be discerned from a normal view of this plane
(Fig. 4 C).
The appearance of these oblique unit cells in the AFM
data rather than the more obvious ones can be attributed to
the unpredictable convolution of the AFM tip and sample
during imaging, in this case resulting in the oblique cells
dominating the force contrast and corresponding frequency
components of the Fourier data. Despite this, the cylindrical
features clearly indicate that the morphology of the bovine
insulin crystals is dominated by (010) and (110) planes, and
the lattice constants of the cells deduced from the Fourier
analysis support these assignments. The occurrence of both
planes in the same region is reasonable, as (010) and (110)
have a common zone axis (the c axis), which is also con-
sistent with the parallelism of the cylinders in region 2.
Furthermore, the cylinders in region 1 are nominally parallel
to those in region 2, arguing that the facet of region 1 grew
from the large face in a commensurate manner. Interest-
ingly, the insulin hexamers on the (010) and (110) faces are
exposed “edge on” to the aqueous medium, in contrast to the
(001) plane, which exposes the upper surface of the hex-
amers (Baker et al., 1988).
Crystal dissolution, which can influence pharmacokinet-
ics, depends upon both the orientation of the constituent
molecules on specific crystal planes and the relative ex-
posed areas of these planes. The TMAFM images acquired
in crystallization liquor indicated that human and porcine
ultralente insulin crystals exhibited large (001) crystal ter-
races, whereas these planes were not evident for the bovine
analog. This suggested that the facile dissolution of human
and porcine ultralente insulin crystals may be attributed to
the predominance of (001) crystal planes. The insulin hex-
amers are oriented on the (001) and (001) crystal planes
such that the upper and lower surfaces of the hexamers are
exposed (Figs. 3 and 4). This orientation would allow sol-
vent to penetrate the crystal surface through the center of the
hexamer, where Zn2 ions reside, and through continuous
interstitial solvent channels located between triads of insulin
hexamer stacks (oriented along the c axis). In contrast,
bovine ultralente crystals exhibited faces that were assign-
able to the densely packed (010) and (110) planes. The
edge-on orientation of the hexamers on these crystal planes
would inhibit solvent access to the individual hexamers; in
particular, the centers of the hexamers and the solvent
channels are not exposed on these surfaces. This restricted
solvent access to these regions may account for the unique
and more desirable basal time action of bovine ultralente.
Although speculative, this argues that dissolution occurs via
release of intact insulin hexamers rather than by dissociation
of monomers.
All of the ultralente forms were prepared from identical
crystallization liquors in this study, arguing against solvent-
mediated crystallization effects. Although a high degree of
sequence homology exists between bovine, porcine, and
human insulins, key differences exist in the A-chain region
(Table 1). In the human and porcine insulins, residues A8
and A10 are Thr and Ile, respectively, whereas in bovine
insulin, these residues are replaced with Ala and Val. These
sequence differences occur in a region of the insulin A-
chain that is not involved directly in insulin monomer-
monomer interactions. However, inspection of the R3 2-Zn
porcine insulin structure revealed that this region is in-
volved in hexamer-hexamer contacts between the upper and
lower surfaces of the donut-shaped insulin hexamers as they
stack along the c axis. Modeling of the bovine insulin
hexamer reveals a twofold increase in exposed hydrophobic
area compared to the porcine analog as a result of these
sequence substitutions, with this increase confined entirely
to the upper and lower surfaces of the insulin hexamer (Fig.
5). This is accompanied by a 25% reduction of the hydro-
philic area on the same surfaces. This argues that formation
of the hexamer stacks, which constitute the predominant
(110) and (010) planes of the bovine ultralente crystals, is
favored because of increased hydrophobic stabilization
forces, an effect that is enhanced further by high salt con-
centrations during crystallization (Melander and Horvath,
1977). The morphology of the bovine ultralente crystals
allows these hydrophobic regions to be buried beneath the
surface of the (010) and (110) planes so as to avoid contact
with the aqueous medium. This is reminiscent of observa-
tions for multimeric proteins, for which hydrophobic sub-
unit patches typically are hidden at the interfaces between
subunits and are not readily accessible to solvent (Lijnzaad
and Argos, 1997). We note that the B30 residue in bovine
and porcine insulins (Ala) differs from that of human insulin
(Thr). This argues that the B30 residues, which are involved
in interhexamer contacts in the (001) plane (Baker et al.,
1988; Yip et al., 1998), do not play a significant role in
determining the morphological properties of the ultralente
insulins.
It is also reasonable to suggest that the increased hydro-
phobic character of the upper and lower surfaces of the
bovine insulin hexamer favors a growth mechanism in
which hexamers attach preferentially along the c axis. In-
sulin hexamers may organize preferentially into “short-
stack” precrystalline aggregates to allow hydrophilic inter-
actions between the edges of the insulin hexamer and the
surrounding solvent while minimizing exposure of hydro-
phobic domains to the solvent (Fig. 3 B). In human or
porcine insulins, the reduced hydrophobic character on the
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hexamer surface allows the lateral interhexamer contacts,
which are hydrogen bonding and electrostatic in nature
(Baker et al., 1988), to dominate, so that the hexamers
assemble into the two-dimensional (001) layers rather than
stacks (Fig. 3 A). This leads to large areas for the (001) faces
of human and porcine insulin, as observed for numerous
wild-type, recombinant, and analog insulins that crystallized
in the R3 space group (Yip et al., 1996, 1997). The hydro-
FIGURE 4 (A–C) Wireframe mo-
lecular models of the insulin hexamer
packing in the R3 space group sym-
metry. Residues 8–10 of the A-chain
are depicted as space filling. Only
some of the hexamers have been
drawn completely; the remaining
ones are depicted only by the space-
filled residues A8–A10. (A) Normal
view of the (001) crystal plane illus-
trating the hexagonally ordered layer
insulin hexamers. (B, C) View of the
(B) (010) and (C) (110) planes, which
contain cylindrical stacks of insulin
hexamers laying in-plane with the
edges of the hexamer exposed at the
surface. Each face can be described
by either a rectangular or an oblique
unit cell, as depicted. The oblique
cell on the (010) plane in B has lattice
constants of 34.4 Å, 89.4 Å, and 60°,
and the oblique cell on the (110)
plane in C has lattice constants of 34
Å  43 Å  75°. These values agree
reasonably with those deduced from
the AFM data. The slightly smaller
lattice constants measured by AFM
can be attributed to intrinsic measure-
ment error and to errors introduced
from nonparallelism between the
scanning tip and the crystal facet.
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phobic terms apparently dominate over these lateral inter-
actions in bovine insulin crystallization such that growth of
the (110) and (010) faces is favored over growth of the
(001) layers.
The observed behavior suggests that, like pH and ionic
strength (Durbin and Feher, 1996; Tiller, 1991), minor
sequence changes can cause subtle changes in the free
energy of hexamer attachment during crystallization. Simi-
lar observations were reported by us for the LysB28ProB29
insulin analog, which exhibited crystal growth characteris-
tics that differed from native forms because of a sequence
inversion in the B-chain (Yip et al., 1998). It has been
suggested that protein-protein contacts in protein crystals
involve exterior surfaces with compositions (aromatic C
atoms, aliphatic C atoms, hydrogen bond donors, hydrogen
bond acceptors) that are statistically identical to the rest of
the protein surface, which led to the suggestion that protein-
protein contacts were random and bear little resemblance to
any specific recognition processes (Carugo and Argos,
1997). However, the observations here argue that the sur-
face character and properties of the ultralente bovine and
human/porcine hexamers are not statistically insignificant.
On the contrary, these differences are sufficient to affect
hexamer-hexamer association during crystallization and sig-
nificantly alter crystal morphology.
It is well known that the conformation of the insulin
hexamer depends on the crystallization conditions, with the
individual monomers adopting one of three possible states:
T-, R-, or Rf (Ciszak et al., 1995; Kaarsholm, 1989; Dere-
wenda et al., 1989). In the T and R state monomers, the
residues B1–B8 of the N-terminus of the insulin B-chain are
in extended and -helical conformations, respectively,
whereas in the “frayed” -helix or Rf monomer state, the
-helix is truncated, with residues B1 through B3 existing in
an extended state. The T 3 R transition is induced by
phenolic ligands that bind to hydrophobic pockets, thereby
stabilizing the helical conformation of the B1–B8 residues.
We cannot discern tertiary or secondary structure by AFM;
therefore we cannot definitively assign a motif to the insulin
monomers or the hexamer. However, the absence of phe-
nolic ligands in the present study would suggest a T6 hex-
amer, a conjecture supported by preliminary powder dif-
fraction studies (G. D. Smith, personal communication).
The present study demonstrates that in situ AFM enables
determination of molecular packing, space group symmetry,
and interfacial structures of various crystalline ultralente
insulin forms. Before the AFM studies described here, the
small crystal dimensions and poorly defined crystal mor-
phologies of ultralente insulin crystals precluded both crys-
tal indexing and structure determination. Consequently, it
has been difficult to elucidate the underlying reasons for the
reputed different pharmacokinetics of the various ultralente
formulations. Our TMAFM studies provide evidence that
the different time actions of these formulations stem from
morphology differences and the related packing and orien-
tations of insulin hexamers at the crystal-solution interface,
which can influence the contribution of microcrystal disso-
lution to the pharmacokinetics. Molecular modeling indi-
cates that the upper and lower surfaces of the bovine insulin
hexamer have greater hydrophobicity than those of its hu-
man and porcine counterparts, arguing that the unique mor-
phology of the bovine form is a consequence of hydropho-
bically driven hexamer assembly. Such effects can have a
significant impact on the physical properties and therapeutic
efficacy of crystalline protein formulations.
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TABLE 1 Amino acid sequences for bovine, human, and
porcine insulins for residues 6–12 of the insulin A chain
A-chain residue number: 6 7 8 9 10 11 12
Bovine Cys Cys Ala Ser Val Cys Ser
Human Cys Cys Thr Ser Ile Cys Ser
Porcine Cys Cys Thr Ser Ile Cys Ser
Those residues that differ are highlighted in bold.
FIGURE 5 Molecular models of
the surfaces of (A) porcine and (B)
bovine insulin hexamers. These mod-
els depict exposed hydrophobic (ma-
genta) and hydrophilic (green) re-
gions as viewed down the threefold
axis of the insulin hexamer along the
c axis, looking into the center of the
hexamers where the Zn2 ions re-
side. The increase in hydrophobic
character of the upper and lower sur-
faces of the bovine insulin hexamer
in B is due to the replacement of the
Thr and Ile residues at positions 8
and 10, respectively, of the porcine
insulin A-chain, with Ala and Val.
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